SCHEMBL4964023

SCHEMBL4964023

[CH2]Cc1cc(OC)cc(OC)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.44
APLNR P35414 1/20 0.39
CYP3A4 P08684 2/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
ALDH1A1 P00352 3/20 0.39
IDO1 P14902 2/20 0.38
ADRA1A P35348 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
HSD17B10 Q99714 2/20 0.36
HTR2A P28223 1/20 0.36
CYP19A1 P11511 1/20 0.35
NQO2 P16083 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13067433 0.82 CYP1A2 (0.46) CYP1A2APLNRCYP3A4CA12CA1
SCHEMBL3397380 0.80 CYP1A2 (0.44) CYP1A2APLNRCYP3A4CA12CA1
SCHEMBL13027262 0.79 CYP1A2 (0.41) CYP1A2APLNRCYP3A4CA12CA1
SCHEMBL29153604 0.78 CYP1A2 (0.47) CYP1A2APLNRCYP3A4CA12CA1
SCHEMBL862161 0.78 ALDH1A1 (0.56) CYP1A2CYP3A4CA12CA1CA2
SCHEMBL28760720 0.77 CYP1A2 (0.46) CYP1A2APLNRCYP3A4CA12CA1
SCHEMBL4713704 0.76 CYP1A2 (0.41) CYP1A2APLNRCYP3A4CA12CA1
SCHEMBL13027338 0.75 CYP1A2 (0.38) CYP1A2APLNRCYP3A4CA12CA1
SCHEMBL15672395 0.74 CYP1A2 (0.44) CYP1A2APLNRCYP3A4CA12CA1
SCHEMBL25554478 0.74 ALOX5 (0.52) CYP1A2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1934201-A1 DEUTERATED INHIBITORS OF GASTRIC H+, K+-ATPASE WITH ENHANCED THERAPEUTIC PROPERTIES Auspex Pharmaceuticals Inc. (US) 2008-06-25 EP disclosed
EP-1778702-A2 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2007-05-02 EP disclosed
WO-2007041630-A1 DEUTERATED INHIBITORS OF GASTRIC H+, K+-ATPASE WITH ENHANCED THERAPEUTIC PROPERTIES AUSPEX PHARMACEUTICALS, INC. (US) 2007-04-12 WO disclosed
WO-2006020276-A2 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2006-02-23 WO disclosed